Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Southwest Airlines Co (LUV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Southwest Airlines Co — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $358.58 (market cap $9.43B), while Southwest Airlines Co trades at $45.1 (market cap $22.27B). The key difference: Southwest Airlines Co is far larger — about 2.4× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Southwest Airlines Co pays a 1.58% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | LUV | |
|---|---|---|
Market Cap | $9.43B | $22.27B |
Sector | Health | Industrials |
52-Week High | $356.25 | $54.80 |
52-Week Low | $241.71 | $29.67 |
Enterprise Value | $9.18B | $25.37B |
Dividend Yield | — | 1.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Rad Laboratories (BIO) trades at $357.58, up 0.86% today, near its 52-week high. The stock shows a bullish technical trend with strong moving average signals, though oscillators indicate overbought conditions. Fundamentally, the company reported a Q2 2026 earnings beat with EPS of $2.62 versus $1.75 expected, and net income for 2025 reached $759.9 million, a significant recovery from prior years. Analyst sentiment is positive with a consensus buy rating and a $350 price target, though the P/E ratio of 43.39 suggests a premium valuation.
The outlook for BIO is cautiously optimistic, driven by earnings momentum and improving cash flow, but risks include high valuation, competitive pressures in life sciences, and reliance on academic research markets. Upside potential exists if international revenue trends strengthen, but investors should monitor margin sustainability and debt levels, which have improved but remain a focus.
Southwest Airlines (LUV) trades at $44.91, showing minimal daily movement. The stock exhibits a bearish technical trend, with key support at $45 and resistance at $46. Fundamentally, revenue grew to $28.06B in 2025, though net income margin compressed to 1.57%. Recent Q2 2026 earnings beat expectations with EPS of $0.94 versus $0.51 expected, while Q1 2026 missed. The company maintains a dividend of $0.18 per share and is focusing on business travel expansion.
LUV presents a mixed outlook. Analyst consensus is a Buy with a $53.86 price target, implying ~20% upside, supported by earnings rebound and strategic initiatives. However, risks include fuel cost volatility, competitive pressures, and bearish technical indicators. Investors should weigh solid liquidity and growth initiatives against margin pressures and macroeconomic sensitivities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
